Clinical Trial Update: Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for low-dose nivolumab in adults living with HIV on antiretroviral therapy (Phase 1/Phase 2), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: University of Melbourne | Conditions: HIV I Infection | Phase 1, Phase 2 | Status: RECRUITING